We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-19.14%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$157M
AUM Growth
-$52.5M
Cap. Flow
-$4.5M
Cap. Flow %
-2.88%
Top 10 Hldgs %
27.76%
Holding
169
New
10
Increased
44
Reduced
55
Closed
23

Top Buys

Rank Stock Value
1
FLRN icon
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
+$1.3M
2
ARCC icon
Ares Capital
ARCC
+$919K
3
BMY icon
Bristol-Myers Squibb
BMY
+$799K
4
FPX icon
First Trust US Equity Opportunities ETF
FPX
+$686K
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$655K

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.56M
2
LLY icon
Eli Lilly
LLY
+$1.37M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$562K
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$398K
5
CCXI
ChemoCentryx, Inc.
CCXI
+$396K

Sector Composition

Rank Sector Weight
1 Healthcare 25.5%
2 Technology 10.31%
3 Consumer Discretionary 7.05%
4 Financials 6.49%
5 Communication Services 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10.5M 6.68%
204,912
-53,100
-21% -$3.56M
IVV icon
2
iShares Core S&P 500 ETF
IVV
$902B
$5.09M 3.25%
19,710
+31
+0.2% +$9.5K
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$4.13M 2.64%
24,758
-346
-1% -$67.7K
AMZN icon
4
Amazon
AMZN
$2.96T
$3.84M 2.45%
39,360
+1,640
+4% +$159K
MDB icon
5
MongoDB
MDB
$32.1B
$3.51M 2.24%
25,712
+194
+0.8% +$28.6K
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$3.34M 2.13%
71,236
-8,772
-11% -$562K
V icon
7
Visa
V
$677B
$3.31M 2.11%
20,558
-76
-0.4% -$14.3K
MGK icon
8
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.2B
$3.31M 2.11%
130,040
+11,535
+10% +$333K
IYK icon
9
iShares US Consumer Staples ETF
IYK
$1.41B
$3.24M 2.07%
89,919
+8,571
+11% +$363K
GILD icon
10
Gilead Sciences
GILD
$165B
$3.23M 2.06%
43,252
-1,308
-3% -$90.4K
BBIO icon
11
BridgeBio Pharma
BBIO
$16.5B
$2.99M 1.91%
103,250
-1,150
-1% -$35.7K
CVS icon
12
CVS Health
CVS
$122B
$2.99M 1.91%
50,329
-244
-0.5% -$16.3K
MO icon
13
Altria Group
MO
$114B
$2.85M 1.82%
73,666
-540
-0.7% -$24K
DAY
14
DELISTED
Dayforce
DAY
$2.61M 1.67%
52,140
+1,000
+2% +$66.2K
TPL icon
15
Texas Pacific Land
TPL
$23.5B
$2.6M 1.66%
61,470
+4,383
+8% +$321K
JNJ icon
16
Johnson & Johnson
JNJ
$625B
$2.36M 1.51%
17,987
-108
-0.6% -$15.3K
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.32M 1.48%
325,645
-10,466
-3% -$131K
PM icon
18
Philip Morris
PM
$295B
$2.27M 1.45%
31,098
-250
-0.8% -$20.6K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4.33T
$2.26M 1.44%
38,860
+100
+0.3% +$6.78K
SBAC icon
20
SBA Communications
SBAC
$19.5B
$2.21M 1.41%
8,200
-500
-6% -$132K
AAPL icon
21
Apple
AAPL
$4.57T
$2.15M 1.37%
33,792
+828
+3% +$60.9K
BIIB icon
22
Biogen
BIIB
$30.7B
$2.14M 1.37%
6,760
-1,220
-15% -$370K
DGRO icon
23
iShares Core Dividend Growth ETF
DGRO
$43.5B
$2.12M 1.35%
64,975
+4,538
+8% +$178K
UNP icon
24
Union Pacific
UNP
$174B
$2.07M 1.32%
14,667
-1,650
-10% -$273K
IWB icon
25
iShares Russell 1000 ETF
IWB
$50.1B
$2.04M 1.3%
14,396
-40
-0.3% -$6.76K
1
2 3 4 5

Similar funds

CIM
Chiron Investment Management New York $300M AUM 49.09% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
FWM
Fairhaven Wealth Management Oak Brook, Illinois $320M AUM 17.7% 1-Year Est. Return
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
AP
Agilis Partners Waltham, Massachusetts $332M AUM 10.57% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Fernwood Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, Fernwood Investment Management held 169 positions worth $157M, down 25% from $209M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Fernwood Investment Management's Q1 2020 filing shows 10 new, 44 increased, 55 reduced and 23 closed positions. Its largest new stake was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 42,920 shares worth $1.26M. The largest sale was Global Blood Therapeutics, Inc., an estimated $3.56M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Fernwood Investment Management's largest Q1 2020 buy was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 42,920 shares worth $1.26M.
  • Fernwood Investment Management added most to Ares Capital in Q1 2020, an estimated $919K increase.
  • Fernwood Investment Management's biggest Q1 2020 reduction was Global Blood Therapeutics, Inc., cutting an estimated $3.56M.
  • Fernwood Investment Management fully exited ChemoCentryx, Inc. in Q1 2020, selling an estimated $396K.
  • Fernwood Investment Management's ten largest holdings make up 28% of its $157M portfolio in Q1 2020.
  • Fernwood Investment Management opened 10 new positions and closed 23 in Q1 2020.
  • Fernwood Investment Management's portfolio value fell 25% quarter-over-quarter to $157M.

Based on Fernwood Investment Management's 13F filing for Q1 2020, filed 30 Apr 2020.